ANCO’s ASCO Highlights 2019
2019 ANCO's ASCO Highlights in Metastatic Bladder Cancer: Should We Add Bevacizumab to Chemo, Is There a Role of Maintenance IO After Chemo, & New Data on Enfortumab Vedotin
By
ANCO’s ASCO Highlights 2019
FEATURING
Sumit Shah
By
ANCO’s ASCO Highlights 2019
FEATURING
Sumit Shah
Comments 0
Login to view comments.
Click here to Login
